<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://2medical.news/2026/10/28/multi-method-machine-learning-identification-of-il11-as-a-key-gene-in-kidney-stone-disease-mechanistic-clues-and-diagnostic-potential/</loc><news:news><news:publication><news:name>2 Medical News</news:name><news:language>en-gb</news:language></news:publication><news:publication_date>2026-10-28T08:00:03+00:00</news:publication_date><news:title>Multi-method Machine-Learning Identification of IL11 as a Key Gene in Kidney Stone Disease: Mechanistic Clues and Diagnostic Potential</news:title><news:keywords>Kidney, stones, machine-learning</news:keywords></news:news></url><url><loc>https://2medical.news/2026/10/27/infliximab-monotherapy-as-first-line-treatment-for-hepatic-splenic-and-pulmonary-sarcoidosis-in-a-patient-with-high-cardiometabolic-risk/</loc><news:news><news:publication><news:name>2 Medical News</news:name><news:language>en-gb</news:language></news:publication><news:publication_date>2026-10-27T08:00:02+00:00</news:publication_date><news:title>Infliximab Monotherapy as First-Line Treatment for Hepatic, Splenic, and Pulmonary Sarcoidosis in a Patient With High Cardiometabolic Risk</news:title><news:keywords>sarcoidosis</news:keywords></news:news></url></urlset>